Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 168

1.

[Drug therapy for AD/HD investigation of usefulness of extended-release methylphenidate and atomoxetine from the viewpoint of persistency rate].

Sugama M, Ishizaki A.

No To Hattatsu. 2014 Jan;46(1):22-5. Japanese.

PMID:
24620426
[PubMed - indexed for MEDLINE]
2.

Pharmacological treatment for attention deficit hyperactivity disorder: functional outcomes in children and adolescents from non-Western countries.

Altin M, El-Shafei AA, Yu M, Desaiah D, Treuer T, Zavadenko N, Gao HY.

Drugs Context. 2013 Sep 13;2013:212260. doi: 10.7573/dic.212260. eCollection 2013 Sep 13.

PMID:
24432046
[PubMed]
Free PMC Article
3.

What place for lisdexamfetamine in children and adolescents with ADHD?

[No authors listed]

Drug Ther Bull. 2013 Oct;51(10):114-7. doi: 10.1136/dtb.2013.10.0208.

PMID:
24113146
[PubMed - indexed for MEDLINE]
4.

Treatment persistence in attention deficit/hyperactivity disorder: a retrospective analysis of patients initiated on lisdexamfetamine vs other medications.

Setyawan J, Guérin A, Hodgkins P, Gauthier G, Cloutier M, Wu E, Erder MH.

J Med Econ. 2013 Nov;16(11):1275-89. doi: 10.3111/13696998.2013.839947. Epub 2013 Sep 19.

PMID:
24004347
[PubMed - indexed for MEDLINE]
5.

[Autism and attention deficit hyperactivity disorder: pharmacological intervention].

Fernández-Jaén A, Martín Fernández-Mayoralas D, Fernández-Perrone AL, Calleja-Pérez B, Muñoz-Jareño N, López-Arribas S.

Rev Neurol. 2013 Sep 6;57 Suppl 1:S205-10. Review. Spanish.

PMID:
23897149
[PubMed - indexed for MEDLINE]
Free Article
6.

Effects of stimulants and atomoxetine on cortisol levels in children with ADHD.

Isaksson J, Hogmark Å, Nilsson KW, Lindblad F.

Psychiatry Res. 2013 Oct 30;209(3):740-1. doi: 10.1016/j.psychres.2013.06.011. Epub 2013 Jul 11.

PMID:
23850434
[PubMed - indexed for MEDLINE]
7.

Current Australian pediatric practice in the assessment and treatment of ADHD.

Efron D, Davies S, Sciberras E.

Acad Pediatr. 2013 Jul-Aug;13(4):328-33. doi: 10.1016/j.acap.2013.03.009.

PMID:
23830018
[PubMed - indexed for MEDLINE]
8.

[ADHD register: post-marketing evaluation of the benefit-risk profile of drugs and promotion of the appropriateness].

Panei P, Arcieri R.

Recenti Prog Med. 2013 Jun;104(6):254-61. doi: 10.1701/1295.14326. Italian.

PMID:
23801229
[PubMed - indexed for MEDLINE]
9.

Comparing treatment adherence of lisdexamfetamine and other medications for the treatment of attention deficit/hyperactivity disorder: a retrospective analysis.

Setyawan J, Hodgkins P, Guérin A, Gauthier G, Cloutier M, Wu EQ, Erder MH.

J Med Econ. 2013 Jul;16(7):962-75. doi: 10.3111/13696998.2013.800524. Epub 2013 Jun 7.

PMID:
23621503
[PubMed - indexed for MEDLINE]
10.

A systematic review of combination therapy with stimulants and atomoxetine for attention-deficit/hyperactivity disorder, including patient characteristics, treatment strategies, effectiveness, and tolerability.

Treuer T, Gau SS, Méndez L, Montgomery W, Monk JA, Altin M, Wu S, Lin CC, Dueñas HJ.

J Child Adolesc Psychopharmacol. 2013 Apr;23(3):179-93. doi: 10.1089/cap.2012.0093. Epub 2013 Apr 6. Review.

PMID:
23560600
[PubMed - indexed for MEDLINE]
Free PMC Article
11.

Methylphenidate and atomoxetine for treatment of nocturnal enuresis in a child with attention-deficit hyperactivity disorder.

Bahali K, Ipek H, Uneri OS.

Eur Child Adolesc Psychiatry. 2013 Oct;22(10):649-50. doi: 10.1007/s00787-013-0414-x. Epub 2013 Apr 4. No abstract available.

PMID:
23553575
[PubMed - indexed for MEDLINE]
12.

Caregiver survey of pharmacotherapy to treat attention deficit/hyperactivity disorder in individuals with Williams syndrome.

Martens MA, Seyfer DL, Andridge RR, Foster JE, McClure KE, Coury DL.

Res Dev Disabil. 2013 May;34(5):1700-9. doi: 10.1016/j.ridd.2013.02.015. Epub 2013 Mar 15.

PMID:
23500164
[PubMed - indexed for MEDLINE]
13.

Tourette Syndrome and comorbid ADHD: current pharmacological treatment options.

Rizzo R, Gulisano M, Calì PV, Curatolo P.

Eur J Paediatr Neurol. 2013 Sep;17(5):421-8. doi: 10.1016/j.ejpn.2013.01.005. Epub 2013 Mar 7. Review.

PMID:
23473832
[PubMed - indexed for MEDLINE]
14.

[Bases for the selection of pharmacological treatment in attention deficit hyperactivity disorder].

Soutullo C, Alvarez-Gomez MJ.

Rev Neurol. 2013 Feb 22;56 Suppl 1:S119-29. Review. Spanish.

PMID:
23446713
[PubMed - indexed for MEDLINE]
Free Article
15.

Pharmacology and pharmacogenetics of pediatric ADHD with associated aggression: a review.

Patel BD, Barzman DH.

Psychiatr Q. 2013 Dec;84(4):407-15. doi: 10.1007/s11126-013-9253-7. Review.

PMID:
23443759
[PubMed - indexed for MEDLINE]
16.

Cardiovascular measures in children and adolescents with attention-deficit/hyperactivity disorder who are new users of methylphenidate and atomoxetine.

Arcieri R, Germinario EA, Bonati M, Masi G, Zuddas A, Vella S, Chiarotti F, Panei P; Italian Attention-Deficit/Hyperactivity Disorder Regional Reference Centers.

J Child Adolesc Psychopharmacol. 2012 Dec;22(6):423-431.

PMID:
23362511
[PubMed - indexed for MEDLINE]
17.

Practitioner review: current best practice in the management of adverse events during treatment with ADHD medications in children and adolescents.

Cortese S, Holtmann M, Banaschewski T, Buitelaar J, Coghill D, Danckaerts M, Dittmann RW, Graham J, Taylor E, Sergeant J; European ADHD Guidelines Group.

J Child Psychol Psychiatry. 2013 Mar;54(3):227-46. doi: 10.1111/jcpp.12036. Epub 2013 Jan 7. Review.

PMID:
23294014
[PubMed - indexed for MEDLINE]
18.

Drug treatment patterns of attention-deficit/hyperactivity disorder in children and adolescents in Germany: results from a large population-based cohort study.

Garbe E, Mikolajczyk RT, Banaschewski T, Petermann U, Petermann F, Kraut AA, Langner I.

J Child Adolesc Psychopharmacol. 2012 Dec;22(6):452-8. doi: 10.1089/cap.2012.0022.

PMID:
23234588
[PubMed - indexed for MEDLINE]
Free PMC Article
19.

Safety of attention-deficit/hyperactivity disorder medications in children: an intensive pharmacosurveillance monitoring study.

Ruggiero S, Rafaniello C, Bravaccio C, Grimaldi G, Granato R, Pascotto A, Sportiello L, Parretta E, Rinaldi B, Panei P, Rossi F, Capuano A.

J Child Adolesc Psychopharmacol. 2012 Dec;22(6):415-22. doi: 10.1089/cap.2012.0003.

PMID:
23234585
[PubMed - indexed for MEDLINE]
20.

Comparative treatment patterns, resource utilization, and costs in stimulant-treated children with ADHD who require subsequent pharmacotherapy with atypical antipsychotics versus non-antipsychotics.

Sikirica V, Pliszka SR, Betts KA, Hodgkins P, Samuelson T, Xie J, Erder H, Dammerman R, Robertson B, Wu EQ.

J Manag Care Pharm. 2012 Nov-Dec;18(9):676-89.

PMID:
23206211
[PubMed - indexed for MEDLINE]
Free Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk